Elomotecan TFA is a potent inhibitor of topoisomerases I and II. As a camptothecin analogue belonging to the homocamptothecin family (hCPT), Elomotecan TFA demonstrates superior efficacy in reducing the proliferation of various tumor cells compared to other reference anticancer molecules targeting topoisomerases I and II.